Your browser doesn't support javascript.
loading
Health System Costs of Treating Latent Tuberculosis Infection With Four Months of Rifampin Versus Nine Months of Isoniazid in Different Settings.
Bastos, Mayara Lisboa; Campbell, Jonathon R; Oxlade, Olivia; Adjobimey, Menonli; Trajman, Anete; Ruslami, Rovina; Kim, Hee Jin; Baah, Joseph Obeng; Toelle, Brett G; Long, Richard; Hoeppner, Vernon; Elwood, Kevin; Al-Jahdali, Hamdan; Apriani, Lika; Benedetti, Andrea; Schwartzman, Kevin; Menzies, Dick.
Afiliação
  • Bastos ML; State University of Rio de Janeiro, Rio de Janeiro, Brazil, and McGill University, Montreal, Quebec, Canada (M.L.B.).
  • Campbell JR; McGill University, Montreal, Quebec, Canada (J.R.C., A.B., K.S., D.M.).
  • Oxlade O; McGill International TB Center, Montreal, Quebec, Canada (O.O.).
  • Adjobimey M; Centre National Hospitalier Universitaire de Pneumo-Phtisiologie, Cotonou, Benin (M.A.).
  • Trajman A; McGill University, Montreal, Quebec, Canada, and Federal University of Rio de Janeiro, Rio de Janeiro, Brazil (A.T.).
  • Ruslami R; Universtitas Padjadjaran, Bandung, Indonesia (R.R.).
  • Kim HJ; Korean National Tuberculosis Association, Seoul, South Korea (H.J.K.).
  • Baah JO; Komfo Anokye Teaching Hospital, Kumasi, Ghana (J.O.B.).
  • Toelle BG; The University of Sydney, Woolcock Institute of Medical Research, and Sydney Local Health District, Sydney, Australia (B.G.T.).
  • Long R; University of Alberta, Edmonton, Alberta, Canada (R.L.).
  • Hoeppner V; University of Saskatchewan, Saskatoon, Saskatchewan, Canada (V.H.).
  • Elwood K; BC Centre for Disease Control and University of British Columbia, Vancouver, British Columbia, Canada (K.E.).
  • Al-Jahdali H; King Saud University, King Abdulaziz Medical City, Riyadh, Saudi Arabia (H.A.).
  • Apriani L; Universitas Padjadjaran, Bandung, Indonesia (L.A.).
  • Benedetti A; McGill University, Montreal, Quebec, Canada (J.R.C., A.B., K.S., D.M.).
  • Schwartzman K; McGill University, Montreal, Quebec, Canada (J.R.C., A.B., K.S., D.M.).
  • Menzies D; McGill University, Montreal, Quebec, Canada (J.R.C., A.B., K.S., D.M.).
Ann Intern Med ; 173(3): 169-178, 2020 08 04.
Article em En | MEDLINE | ID: mdl-32539440
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifampina / Custos de Cuidados de Saúde / Tuberculose Latente / Isoniazida / Antituberculosos Tipo de estudo: Clinical_trials / Guideline / Health_economic_evaluation Limite: Adult / Child / Female / Humans / Male Idioma: En Revista: Ann Intern Med Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifampina / Custos de Cuidados de Saúde / Tuberculose Latente / Isoniazida / Antituberculosos Tipo de estudo: Clinical_trials / Guideline / Health_economic_evaluation Limite: Adult / Child / Female / Humans / Male Idioma: En Revista: Ann Intern Med Ano de publicação: 2020 Tipo de documento: Article